Literature DB >> 18310678

Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.

Michał Maczewski1, Urszula Mackiewicz.   

Abstract

AIMS: beta-Blockers reduce mortality and morbidity in heart failure. Many of their benefits can be explained solely by heart rate reduction (HRR). We aimed to verify whether the beta-blocker, metoprolol, and the pure heart-rate-reducing agent, ivabradine, have the same effects on haemodynamic function, ventricular remodeling, and Ca2+ handling in post-myocardial infarction (MI) heart failure in rat. METHODS AND
RESULTS: Metoprolol (250 mg/kg/day) or ivabradine (10 mg/kg/day), offering similar HRR, or no treatment, was started 24 h after an induction of MI or sham surgery in rat. Eight weeks post-MI metoprolol and ivabradine similarly partially prevented deterioration of left ventricular (LV) ejection fraction and reduced post-MI LV wall stress. However, metoprolol partially prevented LV dilation, whereas ivabradine potentiated LV hypertrophy. Metoprolol, but not ivabradine, partially prevented post-MI chronotropic incompetence. Metoprolol markedly, whereas ivabradine mildly, increased the amplitude of the Ca2+ transient in post-MI cardiomyocytes. Ivabradine, but not metoprolol, partially prevented the MI-induced depression of sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity, while metoprolol, but not ivabradine, suppressed Na+/Ca2+ exchanger (NCX) overactivity and normalized Ca2+ sensitivity of ryanodine receptors.
CONCLUSION: Although both metoprolol and ivabradine comparably prevented post-MI deterioration of haemodynamic function in the rat, metoprolol had additional potentially beneficial effects; it prevented LV dilation and hypertrophy, chronotropic incompetence, strongly increased contractility of isolated cardiomyocytes, and prevented the potentially proarrhythmic increase in NCX activity. This indicates that pure HRR does not account for effects of beta-blockade in the post-MI setting. Metoprolol and ivabradine similarly improve LV function, although differently affect LV morphology and cellular Ca2+ handling in the post-infarction rat heart.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310678     DOI: 10.1093/cvr/cvn057

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  30 in total

Review 1.  To scale or not to scale: the principles of dose extrapolation.

Authors:  Vijay Sharma; John H McNeill
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

2.  Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes.

Authors:  Joon Lee; Mark A Stagg; Satsuki Fukushima; Gopal K R Soppa; Urszula Siedlecka; Samuel J Youssef; Ken Suzuki; Magdi H Yacoub; Cesare M N Terracciano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

3.  Mineralocorticoid and AT1 receptors in the paraventricular nucleus contribute to sympathetic hyperactivity and cardiac dysfunction in rats post myocardial infarct.

Authors:  Bing S Huang; Aidong Chen; Monir Ahmad; Hong-Wei Wang; Frans H H Leenen
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

4.  β-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction.

Authors:  Biyi Chen; Yue Li; Shuxia Jiang; Yu-Ping Xie; Ang Guo; William Kutschke; Kathy Zimmerman; Robert M Weiss; Francis J Miller; Mark E Anderson; Long-Sheng Song
Journal:  FASEB J       Date:  2012-02-28       Impact factor: 5.191

5.  Acipimox-enhanced ¹⁸F-fluorodeoxyglucose positron emission tomography for characterizing and predicting early remodeling in the rat infarct model.

Authors:  Mélanie Bousquenaud; Fatiha Maskali; Sylvain Poussier; Pierre-Yves Marie; Henri Boutley; Gilles Karcher; Daniel R Wagner; Yvan Devaux
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-25       Impact factor: 2.357

6.  Cardioprotective effects of Qishen Granule () on sarcoplasmic reticulum Ca2+ handling in heart failure rats.

Authors:  Ling-Hui Lu; Chun Li; Qi-Yan Wang; Qian Zhang; Yi Zhang; Hui Meng; Yong Wang; Wei Wang
Journal:  Chin J Integr Med       Date:  2017-05-11       Impact factor: 1.978

Review 7.  Heart rate reduction in heart failure: ivabradine or beta blockers?

Authors:  Maya Guglin
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

8.  Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.

Authors:  Nicolas Couvreur; Renaud Tissier; Sandrine Pons; Valérie Chetboul; Vassiliky Gouni; Patrick Bruneval; Chantal Mandet; Jean-Louis Pouchelon; Alain Berdeaux; Bijan Ghaleh
Journal:  Eur Heart J       Date:  2009-12-21       Impact factor: 29.983

9.  Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure.

Authors:  Navneet S Rehsia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2010

10.  Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.

Authors:  Danielle M Trappanese; Yuchuan Liu; Ryan C McCormick; Alessandro Cannavo; Gayani Nanayakkara; Marina M Baskharoun; Harish Jarrett; Felix J Woitek; D Michael Tillson; A Ray Dillon; Fabio A Recchia; Jean-Luc Balligand; Steven R Houser; Walter J Koch; Louis J Dell'Italia; Emily J Tsai
Journal:  Basic Res Cardiol       Date:  2014-12-06       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.